AgPlus Diagnostics

AgPlus Diagnostics has developed a diagnostic platform technology based on research conducted at the UK’s National Physical Laboratory (NPL).

AgPlus’ platform technology combines novel electrochemistry and metallic nanoparticles signalling with diagnostic immunoassays to provide high sensitivity and fully quantitative analyte detection. The AgPlus ADVANTAGE handheld portable reader and single-use test cartridge are expected to be used across multiple applications and sectors, critically where fast cost-effective diagnostic results will enable users to make decisions, with confidence, in minutes, not hours or days.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

Rainbow Seed Fund Invests in AgPlus Diagnostics

28 September 2016 AgPlus’ handheld electrochemical reader to deliver the next generation of rapid diagnostics…

read more

Presentation at Tech Connect World Innovation Conference

Fiona Marshall CEO of AgPlus was invited to speak by the Silver Council at...

read more

Our Vision

To be a recognised market leader in innovative Point of Care diagnosis, matching each...

read more

Advertisement for a QA Associate/ Senior QA Associate

Location: Colworth Science Park, Sharnbrook, Bedfordshire Salary on application dependant on experience Job Description An exciting role...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now